GTC Biotherapeutics (fka GTCB)

[lidopete]

Dear Dewophoile:

When all is said and done, your statement below is one of major drivers that will or will not create value in GTCB. Although most of your response is way over my head, your statement of "orders of magnitude" is clear enough. The only wild card, IMHO would be that the yield continues to increase to the point of a smaller difference between the two.
Thanks for the response

Regards,

Peter

"at the end of the day, with all the refinements over the years, in the best of circumstances yields remain orders of magnitude lower than what gtcb's transgenic platform provides"